ETF Foundry
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.
momentum factor · long-only model fund

Foundry 52-Week High Industry-Neutral Factor ETF

ETF Foundry Research (hypothetical) · rebalanced monthly

FHIRHYPOTHETICAL MODEL
Since ’99
−11%
Expense Ratio
0.35%
placeholder
Holdings
314
cap-weighted
Inception
Nov 2021
placeholder
Full Sharpe
0.11
Ann. Return (LS)
2.8%
Ann. Volatility
24.9%
Max Drawdown
-75.3%
Test Sharpe ’19–26
0.24
Test FF5 α (ann.)
9.6%
vs Fama-French 5
Test FF5 α t-stat
1.39
not significant
Monthly turnover
37%
of the long leg, per rebalance
Cumulative return (LS)
-11%
over 331 months
This fund holds the long leg only
Long leg Sharpe
0.51
what this fund holds
Long leg ann. return
7.7%
buyable, long-only
Long-short Sharpe
0.11
requires shorting
Bottom bucket ann. return
4.9%
the basket shorted

Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.

Hypothetical growth of $1 — long-short backtest

Gross of the placeholder expense ratio and trading costs · not investor results

331 months

Holdings

Every constituent of the long leg — sort, search or filter by sector

314 of 314 · 100.0% of book
TickerCompanySectorMarket capWeight
1NVDA
NVIDIA CORPTechnology$4.91T
36.89%
2LLY
ELI LILLY & COHealthcare$1.11T
8.35%
3V
VISA INCFinancial Services$652.82B
4.91%
4JNJ
JOHNSON & JOHNSONHealthcare$609.12B
4.58%
5ABBV
ABBVIE INCHealthcare$449.63B
3.38%
6GE
GE AEROSPACEIndustrials$361.93B
2.72%
7KO
COCA COLA COConsumer Defensive$350.91B
2.64%
8MRK
MERCK & CO INCHealthcare$314.90B
2.37%
9PM
PHILIP MORRIS INTERNATIONAL INCConsumer Defensive$300.77B
2.26%
10PANW
PALO ALTO NETWORKS INCTechnology$292.32B
2.20%
11GEV
GE VERNOVA INCUtilities$284.26B
2.14%
12CRWD
CROWDSTRIKE HOLDINGS INCTechnology$206.79B
1.55%
13AMGN
AMGEN INCHealthcare$197.69B
1.49%
14BMY
BRISTOL MYERS SQUIBB COHealthcare$124.04B
0.93%
15MO
ALTRIA GROUP INCConsumer Defensive$123.92B
0.93%
16VRTX
VERTEX PHARMACEUTICALS INCHealthcare$123.26B
0.93%
17NET
CLOUDFLARE INCTechnology$98.14B
0.74%
18MNST
MONSTER BEVERAGE CORPConsumer Defensive$95.36B
0.72%
19SNOW
SNOWFLAKE INCTechnology$93.20B
0.70%
20DDOG
DATADOG INCTechnology$92.08B
0.69%
21MCO
MOODYS CORPFinancial Services$89.25B
0.67%
22ABNB
AIRBNB INCIndustrials$87.98B
0.66%
23JCI
JOHNSON CONTROLS INTERNATIONAL PLCBasic Materials$85.70B
0.64%
24MMM
3M COIndustrials$83.37B
0.63%
25MDLZ
MONDELEZ INTERNATIONAL INCConsumer Defensive$78.30B
0.59%
26EMR
EMERSON ELECTRIC COIndustrials$78.14B
0.59%
27PCAR
PACCAR INCIndustrials$66.42B
0.50%
28CTVA
CORTEVA INCBasic Materials$58.39B
0.44%
29AME
AMETEK INCIndustrials$54.32B
0.41%
30EA
ELECTRONIC ARTS INCCommunication Services$52.38B
0.39%
31EBAY
EBAY INCConsumer Cyclical$49.75B
0.37%
32EW
EDWARDS LIFESCIENCES CORPHealthcare$49.36B
0.37%
33GRMN
GARMIN LTDTechnology$48.13B
0.36%
34XYZ
BLOCK INCTechnology$47.58B
0.36%
35MSCI
MSCI INCFinancial Services$45.77B
0.34%
36LYV
LIVE NATION ENTERTAINMENT INCCommunication Services$42.45B
0.32%
37KDP
KEURIG DR PEPPER INCConsumer Defensive$42.05B
0.32%
38ADM
ARCHER-DANIELS-MIDLAND COConsumer Defensive$41.40B
0.31%
39RVMD
REVOLUTION MEDICINES INCHealthcare$39.58B
0.30%
40VMC
VULCAN MATERIALS COBasic Materials$37.41B
0.28%
41RPRX
ROYALTY PHARMA PLCHealthcare$33.50B
0.25%
42TWLO
TWILIO INCCommunication Services$31.38B
0.24%
43BIIB
BIOGEN INCHealthcare$30.41B
0.23%
44DXCM
DEXCOM INCHealthcare$29.58B
0.22%
45ILMN
ILLUMINA INCHealthcare$28.24B
0.21%
46OKTA
OKTA INCTechnology$25.96B
0.20%
47VRSN
VERISIGN INCTechnology$25.27B
0.19%
48ROIV
ROIVANT SCIENCES LTDHealthcare$24.82B
0.19%
49CPAY
CORPAY INCTechnology$23.91B
0.18%
50FWONA
LIBERTY MEDIA CORPCommunication Services$23.53B
0.18%
51INCY
INCYTE CORPHealthcare$23.42B
0.18%
52WWD
WOODWARD INCIndustrials$23.41B
0.18%
53OMC
OMNICOM GROUP INCCommunication Services$23.29B
0.18%
54ROKU
ROKU INCCommunication Services$21.32B
0.16%
55VTRS
VIATRIS INCHealthcare$20.14B
0.15%
56FTV
FORTIVE CORPTechnology$18.83B
0.14%
57NBIX
NEUROCRINE BIOSCIENCES INCHealthcare$17.18B
0.13%
58BBIO
BRIDGEBIO PHARMA INCHealthcare$15.94B
0.12%
59JAZZ
JAZZ PHARMACEUTICALS PLCHealthcare$15.53B
0.12%
60SOLV
SOLVENTUM CORPHealthcare$14.08B
0.11%
61EXEL
EXELIXIS INCHealthcare$14.06B
0.11%
62HRL
HORMEL FOODS CORPConsumer Defensive$13.97B
0.11%
63RRX
REGAL REXNORD CORPIndustrials$13.77B
0.10%
64ELAN
ELANCO ANIMAL HEALTH INCHealthcare$12.90B
0.10%
65MDGL
MADRIGAL PHARMACEUTICALS INCHealthcare$12.76B
0.10%
66ALGN
ALIGN TECHNOLOGY INCHealthcare$12.66B
0.10%
67AXSM
AXSOME THERAPEUTICS INCHealthcare$11.84B
0.09%
68BF.B
BROWN FORMAN CORPConsumer Defensive$11.74B
0.09%
69BMRN
BIOMARIN PHARMACEUTICAL INCHealthcare$11.52B
0.09%
70TECH
BIO-TECHNE CORPHealthcare$11.29B
0.08%
71CRL
CHARLES RIVER LABORATORIES INTERNATIONAL INCHealthcare$10.81B
0.08%
72CART
INSTACART (MAPLEBEAR INC)Consumer Cyclical$10.77B
0.08%
73FROG
JFROG LTDTechnology$10.72B
0.08%
74KRYS
KRYSTAL BIOTECH INCHealthcare$10.46B
0.08%
75SIRI
SIRIUS XM HOLDINGS INCCommunication Services$10.30B
0.08%
76APGE
APOGEE THERAPEUTICS INCHealthcare$10.10B
0.08%
77LFUS
LITTELFUSE INCTechnology$10.06B
0.08%
78DAR
DARLING INGREDIENTS INCConsumer Defensive$10.03B
0.08%
79AYI
ACUITY INC (DE)Industrials$9.99B
0.08%
80CYTK
CYTOKINETICS INCHealthcare$9.98B
0.07%
81NUVL
NUVALENT INCHealthcare$9.79B
0.07%
82CORT
CORCEPT THERAPEUTICS INCHealthcare$9.72B
0.07%
83MSGS
MADISON SQUARE GARDEN SPORTS CORPCommunication Services$9.56B
0.07%
84KYMR
KYMERA THERAPEUTICS INCHealthcare$9.52B
0.07%
85LTH
LIFE TIME GROUP HOLDINGS INCConsumer Cyclical$9.38B
0.07%
86HALO
HALOZYME THERAPEUTICS INCHealthcare$9.23B
0.07%
87GKOS
GLAUKOS CORPHealthcare$9.21B
0.07%
88PTGX
PROTAGONIST THERAPEUTICS INCHealthcare$9.06B
0.07%
89PRMB
PRIMO BRANDS CORPConsumer Defensive$9.01B
0.07%
90CRNX
CRINETICS PHARMACEUTICALS INCHealthcare$8.84B
0.07%
91ALKS
ALKERMES PLCHealthcare$8.79B
0.07%
92SYRE
SPYRE THERAPEUTICS INCHealthcare$8.70B
0.07%
93TGTX
TG THERAPEUTICS INCHealthcare$8.40B
0.06%
94IMVT
IMMUNOVANT INCHealthcare$8.27B
0.06%
95ETSY
ETSY INCConsumer Cyclical$7.98B
0.06%
96RSI
RUSH STREET INTERACTIVE INCConsumer Cyclical$7.56B
0.06%
97YOU
CLEAR SECURE INCTechnology$7.49B
0.06%
98RYTM
RHYTHM PHARMACEUTICALS INCHealthcare$7.31B
0.05%
99MIRM
MIRUM PHARMACEUTICALS INCHealthcare$7.25B
0.05%
100SLAB
SILICON LABORATORIES INCTechnology$7.17B
0.05%
101DBX
DROPBOX INCTechnology$7.14B
0.05%
102LQDA
LIQUIDIA CORPHealthcare$7.11B
0.05%
103LEA
LEAR CORPConsumer Cyclical$7.10B
0.05%
104LNTH
LANTHEUS HOLDINGS INCHealthcare$7.00B
0.05%
105HNGE
HINGE HEALTH INCHealthcare$6.74B
0.05%
106S
SENTINELONE INCTechnology$6.71B
0.05%
107COGT
COGENT BIOSCIENCES INCHealthcare$6.68B
0.05%
108XENE
XENON PHARMACEUTICALS INCHealthcare$6.60B
0.05%
109CGON
CG ONCOLOGY INCHealthcare$6.34B
0.05%
110SRRK
SCHOLAR ROCK HOLDING CORPHealthcare$6.33B
0.05%
111LGND
LIGAND PHARMACEUTICALS INCHealthcare$6.08B
0.05%
112ERAS
ERASCA INCHealthcare$5.96B
0.04%
113TFX
TELEFLEX INCHealthcare$5.96B
0.04%
114ACIW
ACI WORLDWIDE INCTechnology$5.90B
0.04%
115SEZL
SEZZLE INCFinancial Services$5.87B
0.04%
116DNTH
DIANTHUS THERAPEUTICS INCHealthcare$5.77B
0.04%
117AMRX
AMNEAL PHARMACEUTICALS INCHealthcare$5.69B
0.04%
118QLYS
QUALYS INCTechnology$5.61B
0.04%
119ORKA
ORUKA THERAPEUTICS INCHealthcare$5.59B
0.04%
120TXG
10X GENOMICS INCHealthcare$5.55B
0.04%
121FTDR
FRONTDOOR INCConsumer Cyclical$5.32B
0.04%
122NOVT
NOVANTA INCTechnology$5.30B
0.04%
123TVTX
TRAVERE THERAPEUTICS INCHealthcare$5.27B
0.04%
124MTN
VAIL RESORTS INCConsumer Cyclical$5.27B
0.04%
125XMTR
XOMETRY INCIndustrials$5.18B
0.04%
126RELY
REMITLY GLOBAL INCTechnology$5.08B
0.04%
127ANDG
ANDERSEN GROUP INCConsumer Cyclical$5.02B
0.04%
128HRI
HERC HOLDINGS INCIndustrials$4.99B
0.04%
129KNSA
KINIKSA PHARMACEUTICALS INTERNATIONAL PLCHealthcare$4.92B
0.04%
130DFTX
DEFINIUM THERAPEUTICS INCHealthcare$4.83B
0.04%
131FELE
FRANKLIN ELECTRIC CO INCIndustrials$4.67B
0.04%
132LIVN
LIVANOVA PLCHealthcare$4.43B
0.03%
133AZZ
AZZ INCIndustrials$4.42B
0.03%
134MDU
MDU RESOURCES GROUP INCIndustrials$4.42B
0.03%
135TENB
TENABLE HOLDINGS INCTechnology$4.40B
0.03%
136ACAD
ACADIA PHARMACEUTICALS INCHealthcare$4.38B
0.03%
137VKTX
VIKING THERAPEUTICS INCHealthcare$4.31B
0.03%
138EWTX
EDGEWISE THERAPEUTICS INCHealthcare$4.28B
0.03%
139RHI
ROBERT HALF INCIndustrials$4.28B
0.03%
140COCO
VITA COCO COMPANY INCConsumer Defensive$4.18B
0.03%
141PII
POLARIS INCConsumer Cyclical$4.16B
0.03%
142KFY
KORN FERRYIndustrials$4.00B
0.03%
143ICUI
ICU MEDICAL INCHealthcare$3.94B
0.03%
144DYN
DYNE THERAPEUTICS INCHealthcare$3.92B
0.03%
145CPRX
CATALYST PHARMACEUTICALS INCHealthcare$3.85B
0.03%
146FA
FIRST ADVANTAGE CORPIndustrials$3.83B
0.03%
147RLAY
RELAY THERAPEUTICS INCHealthcare$3.81B
0.03%
148ADPT
ADAPTIVE BIOTECHNOLOGIES CORPHealthcare$3.67B
0.03%
149ALMS
ALUMIS INCHealthcare$3.65B
0.03%
150BATRA
ATLANTA BRAVES HOLDINGS INCCommunication Services$3.63B
0.03%
151ARQT
ARCUTIS BIOTHERAPEUTICS INCHealthcare$3.56B
0.03%
152CNK
CINEMARK HOLDINGS INCCommunication Services$3.55B
0.03%
153OGN
ORGANON & COHealthcare$3.55B
0.03%
154HAE
HAEMONETICS CORPHealthcare$3.54B
0.03%
155ELVN
ENLIVEN THERAPEUTICS INCHealthcare$3.24B
0.02%
156ITGR
INTEGER HOLDINGS CORPHealthcare$3.24B
0.02%
157IDYA
IDEAYA BIOSCIENCES INCHealthcare$3.16B
0.02%
158MBX
MBX BIOSCIENCES INCHealthcare$2.99B
0.02%
159MGRC
MCGRATH RENTCORPIndustrials$2.90B
0.02%
160XRAY
DENTSPLY SIRONA INCHealthcare$2.81B
0.02%
161ABM
ABM INDUSTRIES INCIndustrials$2.79B
0.02%
162CLDX
CELLDEX THERAPEUTICS INCHealthcare$2.77B
0.02%
163WU
WESTERN UNION COFinancial Services$2.77B
0.02%
164VISN
VISTANCE NETWORKS INCTechnology$2.74B
0.02%
165ESTA
ESTABLISHMENT LABS HOLDINGS INCHealthcare$2.72B
0.02%
166GRND
GRINDR INCTechnology$2.71B
0.02%
167TRVI
TREVI THERAPEUTICS INCHealthcare$2.71B
0.02%
168KOD
KODIAK SCIENCES INCHealthcare$2.67B
0.02%
169ATAI
ATAIBECKLEY INCHealthcare$2.66B
0.02%
170PBI
PITNEY BOWES INCIndustrials$2.51B
0.02%
171ASTH
ASTRANA HEALTH INCHealthcare$2.50B
0.02%
172CMPR
CIMPRESS PLCCommunication Services$2.49B
0.02%
173ATKR
ATKORE INCIndustrials$2.48B
0.02%
174BLBD
BLUE BIRD CORPConsumer Cyclical$2.48B
0.02%
175MAN
MANPOWERGROUP INCIndustrials$2.43B
0.02%
176NRIX
NURIX THERAPEUTICS INCHealthcare$2.40B
0.02%
177PAYO
PAYONEER GLOBAL INCTechnology$2.38B
0.02%
178VCEL
VERICEL CORPHealthcare$2.38B
0.02%
179BCRX
BIOCRYST PHARMACEUTICALS INCHealthcare$2.36B
0.02%
180LMAT
LEMAITRE VASCULAR INCHealthcare$2.32B
0.02%
181BAND
BANDWIDTH INCTechnology$2.30B
0.02%
182RAMP
LIVERAMP HOLDINGS INCTechnology$2.28B
0.02%
183PVLA
PALVELLA THERAPEUTICS INCHealthcare$2.26B
0.02%
184FLYW
FLYWIRE CORPTechnology$2.24B
0.02%
185IOVA
IOVANCE BIOTHERAPEUTICS INCHealthcare$2.23B
0.02%
186SION
SIONNA THERAPEUTICS INCHealthcare$2.23B
0.02%
187EVCM
EVERCOMMERCE INCTechnology$2.13B
0.02%
188GLUE
MONTE ROSA THERAPEUTICS INCHealthcare$2.07B
0.02%
189SPB
SPECTRUM BRANDS HOLDINGS INCConsumer Defensive$2.06B
0.02%
190AUPH
AURINIA PHARMACEUTICALS INCHealthcare$2.05B
0.02%
191RAPP
RAPPORT THERAPEUTICS INCHealthcare$2.04B
0.02%
192SNDX
SYNDAX PHARMACEUTICALS INCHealthcare$2.02B
0.02%
193ZD
ZIFF DAVIS INCCommunication Services$1.99B
0.01%
194PLSE
PULSE BIOSCIENCES INCHealthcare$1.98B
0.01%
195AMLX
AMYLYX PHARMACEUTICALS INCHealthcare$1.97B
0.01%
196URGN
UROGEN PHARMA LTDHealthcare$1.96B
0.01%
197DMRA
DAMORA THERAPEUTICS INCHealthcare$1.94B
0.01%
198NEO
NEOGENOMICS INCHealthcare$1.90B
0.01%
199NSP
INSPERITY INCIndustrials$1.89B
0.01%
200MRVI
MARAVAI LIFESCIENCES HOLDINGS INCHealthcare$1.87B
0.01%
201STGW
STAGWELL INCCommunication Services$1.86B
0.01%
202PRG
PROG HOLDINGS INCIndustrials$1.86B
0.01%
203NVCR
NOVOCURE LTDHealthcare$1.84B
0.01%
204SSMR
SUNSHINE MINING & REFINING COBasic Materials$1.83B
0.01%
205BCAX
BICARA THERAPEUTICS INCHealthcare$1.82B
0.01%
206MPLT
MAPLIGHT THERAPEUTICS INCHealthcare$1.72B
0.01%
207INVA
INNOVIVA INCHealthcare$1.60B
0.01%
208IDT
IDT CORPCommunication Services$1.57B
0.01%
209AVBP
ARRIVENT BIOPHARMA INCHealthcare$1.55B
0.01%
210SEPN
SEPTERNA INCHealthcare$1.51B
0.01%
211IART
INTEGRA LIFESCIENCES HOLDINGS CORPHealthcare$1.50B
0.01%
212TBLA
TABOOLACOM LTDCommunication Services$1.44B
0.01%
213BLFS
BIOLIFE SOLUTIONS INCHealthcare$1.42B
0.01%
214AMN
AMN HEALTHCARE SERVICES INCHealthcare$1.36B
0.01%
215BV
BRIGHTVIEW HOLDINGS INCIndustrials$1.35B
0.01%
216XNCR
XENCOR INCHealthcare$1.30B
0.01%
217IRMD
IRADIMED CORPHealthcare$1.24B
0.01%
218CMP
COMPASS MINERALS INTERNATIONAL INCBasic Materials$1.24B
0.01%
219LQDT
LIQUIDITY SERVICES INCConsumer Cyclical$1.23B
0.01%
220AVO
MISSION PRODUCE INCConsumer Defensive$1.20B
0.01%
221DRTS
ALPHA TAU MEDICAL LTDHealthcare$1.19B
0.01%
222AVNS
AVANOS MEDICAL INCHealthcare$1.17B
0.01%
223ETON
ETON PHARMACEUTICALS INCHealthcare$1.16B
0.01%
224CGEM
CULLINAN THERAPEUTICS INCHealthcare$1.09B
0.01%
225GRPN
GROUPON INCCommunication Services$1.06B
0.01%
226KFRC
KFORCE INCIndustrials$1.04B
0.01%
227AVTX
AVALO THERAPEUTICS INCHealthcare$1.02B
0.01%
228BIOA
BIOAGE LABS INCHealthcare$1.01B
0.01%
229PCRX
PACIRA BIOSCIENCES INCHealthcare$1.01B
0.01%
230BVS
BIOVENTUS INCHealthcare$1.01B
0.01%
231FBRX
FORTE BIOSCIENCES INCHealthcare$1.00B
0.01%
232EEX
EMERALD HOLDING INCCommunication Services$998M
0.01%
233ACEL
ACCEL ENTERTAINMENT INCConsumer Cyclical$989M
0.01%
234ANRO
ALTO NEUROSCIENCE INCHealthcare$967M
0.01%
235QNST
QUINSTREET INCCommunication Services$964M
0.01%
236ANNX
ANNEXON INCHealthcare$950M
0.01%
237EVER
EVERQUOTE INCCommunication Services$925M
0.01%
238RDVT
RED VIOLET INCTechnology$920M
0.01%
239LBRX
LB PHARMACEUTICALS INCHealthcare$901M
0.01%
240LYTS
LSI INDUSTRIES INCTechnology$879M
0.01%
241CYRX
CRYOPORT INCIndustrials$832M
0.01%
242HSTM
HEALTHSTREAM INCHealthcare$832M
0.01%
243ACRS
ACLARIS THERAPEUTICS INCHealthcare$793M
0.01%
244WEST
WESTROCK COFFEE COConsumer Defensive$749M
0.01%
245CADL
CANDEL THERAPEUTICS INCHealthcare$746M
0.01%
246MNPR
MONOPAR THERAPEUTICSHealthcare$744M
0.01%
247CLYM
CLIMB BIO INCHealthcare$727M
0.01%
248AURA
AURA BIOSCIENCES INCHealthcare$723M
0.01%
249MCS
MARCUS CORPCommunication Services$708M
0.01%
250CCSI
CONSENSUS CLOUD SOLUTIONS INCTechnology$689M
0.01%
251CASS
CASS INFORMATION SYSTEMS INCIndustrials$686M
0.01%
252RSVR
RESERVOIR MEDIA INCCommunication Services$671M
0.01%
253SWBI
SMITH & WESSON BRANDS INCIndustrials$665M
0.00%
254RMR
RMR GROUP INCReal Estate$662M
0.00%
255TCMD
TACTILE SYSTEMS TECHNOLOGY INCHealthcare$648M
0.00%
256ACHV
ACHIEVE LIFE SCIENCES INCHealthcare$644M
0.00%
257NVRI
ENVIRI CORPIndustrials$643M
0.00%
258TECX
TECTONIC THERAPEUTIC INCHealthcare$615M
0.00%
259PUBM
PUBMATIC INCTechnology$591M
0.00%
260NGNE
NEUROGENE INCHealthcare$590M
0.00%
261STTK
SHATTUCK LABS INCHealthcare$577M
0.00%
262OSPN
ONESPAN INCTechnology$574M
0.00%
263OOMA
OOMA INCCommunication Services$568M
0.00%
264ANGO
ANGIODYNAMICS INCHealthcare$558M
0.00%
265IMMX
IMMIX BIOPHARMA INCHealthcare$558M
0.00%
266NPCE
NEUROPACE INCHealthcare$548M
0.00%
267WNC
WABASH NATIONAL CORPIndustrials$547M
0.00%
268KELYA
KELLY SERVICES INCIndustrials$531M
0.00%
269NVCT
NUVECTIS PHARMA INCHealthcare$508M
0.00%
270XOMA
XOMA ROYALTY CORPHealthcare$504M
0.00%
271NRC
NRC HEALTHHealthcare$491M
0.00%
272LWAY
LIFEWAY FOODS INCConsumer Defensive$488M
0.00%
273PAYS
PAYSIGN INCTechnology$478M
0.00%
274AMCX
AMC GLOBAL MEDIA INCCommunication Services$461M
0.00%
275SI
SHOULDER INNOVATIONS INCHealthcare$448M
0.00%
276QUAD
QUAD/GRAPHICS INCIndustrials$446M
0.00%
277DCTH
DELCATH SYSTEMS INCHealthcare$442M
0.00%
278PBYI
PUMA BIOTECHNOLOGY INCHealthcare$434M
0.00%
279TENX
TENAX THERAPEUTICS INCHealthcare$420M
0.00%
280ABEO
ABEONA THERAPEUTICS INCHealthcare$399M
0.00%
281TBRG
TRUBRIDGE INCHealthcare$394M
0.00%
282FENC
FENNEC PHARMACEUTICALS INCHealthcare$365M
0.00%
283ZNTL
ZENTALIS PHARMACEUTICALS INCHealthcare$364M
0.00%
284ELMD
ELECTROMED INCHealthcare$349M
0.00%
285SEG
SEAPORT ENTERTAINMENT GROUP INCReal Estate$332M
0.00%
286MKTW
MARKETWISE INCTechnology$314M
0.00%
287ALCO
ALICO INCConsumer Defensive$304M
0.00%
288TTRX
TURN THERAPEUTICS INCHealthcare$272M
0.00%
289TBI
TRUEBLUE INCIndustrials$258M
0.00%
290QTTB
Q32 BIO INCHealthcare$255M
0.00%
291LMNR
LIMONEIRA COConsumer Defensive$245M
0.00%
292ARTV
ARTIVA BIOTHERAPEUTICS INCHealthcare$241M
0.00%
293UTMD
UTAH MEDICAL PRODUCTS INCHealthcare$222M
0.00%
294KPTI
KARYOPHARM THERAPEUTICS INCHealthcare$216M
0.00%
295AGEN
AGENUS INCHealthcare$209M
0.00%
296IMUX
IMMUNIC INCHealthcare$207M
0.00%
297FOCL
FOCAL INCHealthcare$204M
0.00%
298DTIL
PRECISION BIOSCIENCES INCHealthcare$203M
0.00%
299ANIK
ANIKA THERAPEUTICS INCHealthcare$203M
0.00%
300FORR
FORRESTER RESEARCH INCIndustrials$200M
0.00%
301AMWL
AMERICAN WELL CORPHealthcare$199M
0.00%
302ACOG
ALPHA COGNITION INCHealthcare$185M
0.00%
303AOUT
AMERICAN OUTDOOR BRANDS INCIndustrials$174M
0.00%
304AMPG
AMPLITECH GROUP INCTechnology$168M
0.00%
305KORE
KORE GROUP HOLDINGS INCCommunication Services$163M
0.00%
306RCEL
AVITA MEDICAL INCHealthcare$157M
0.00%
307CUE
CUE BIOPHARMA INCHealthcare$126M
0.00%
308CPIX
CUMBERLAND PHARMACEUTICALS INCHealthcare$103M
0.00%
309ICCC
IMMUCELL CORPHealthcare$101M
0.00%
310LIXT
LIXTE BIOTECHNOLOGY HOLDINGS INCHealthcare$91M
0.00%
311RLYB
RALLYBIO CORPHealthcare$87M
0.00%
312SOTK
SONO TEK CORPTechnology$86M
0.00%
313CPHC
CANTERBURY PARK HOLDING CORPConsumer Cyclical$82M
0.00%
314BKHA
BLACK HAWK ACQUISITION CORPIndustrials$50M
0.00%

Full long-leg book as of July 2026 · cap-weighted · total market cap $13.31T. Hypothetical model holdings — not a registered fund’s portfolio.

Sector Breakdown

10 sectors
Technology
44.9%
Healthcare
28.4%
Consumer Defensive
8.2%
Industrials
6.3%
Financial Services
6.0%
Utilities
2.1%
Communication Services
1.8%
Basic Materials
1.4%
Consumer Cyclical
0.9%
Real Estate
0.0%

Portfolio Style

Size × value map of the long-leg book

314 classified
Value
Blend
Growth
Large
Mid
Small
2%6
23%40
71%68
<1%12
1%40
1%50
<1%23
<1%25
<1%18

Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 99% toward Large, 85% toward Growth. +2% unclassified (32 missing size/value). Hypothetical holdings — descriptive, not realized P&L.

Tilt over time
Size tilt99% → Large
SmallLarge
Value ↔ growth tilt85% → Growth
ValueGrowth

Capital-weighted centroid of the long leg, December 1998July 2026; the right-hand end is the same value as the box’s dot. 314 names now. Hypothetical holdings — descriptive, not P&L.

Constraint checks

How this book measures against the concentration and liquidity rules — as implemented here

How this book was built

These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.

Passed
1
Failed
4
Not tested
2
Independent checks
7

7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.

2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.

  • With respect to 75% of total assets, no more than 5% may be invested in the securities of any one issuer.

    Required
    >= 75.0%
    Actual
    64.8%
    Margin
    -10.2%
  • No more than 25% of total assets may be invested in the securities of any one issuer.

    Required
    <= 25.0%
    Actual
    36.9%
    Margin
    -11.9%
  • The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).

    Required
    <= 25.0%
    Actual
    37.3%
    Margin
    -12.3%
  • Days required to liquidate the largest position at 20% of one day's dollar volume.

    Required
    <= 7.0 days
    Actual
    unbounded
    Margin
Reported separately — arithmetically implied

Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.

No verdict sits within 1.0pp of its limit.

Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700

Measured on the 2026-07 formation date across 314 holdings (cap-weighted). A different formation date can produce different verdicts.

Derivatives risk (Rule 18f-4)

Whether this long-only book is subject to the VaR tests at all

This assessment describes the long-only book this fund holds — the top bucket only.

Governing rule
Rule 18f-4(c)(4) limited derivatives user exception

This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.

Limited derivatives user exceptionby construction

Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.

Qualifies
Required
<= 10% of net assets
Exposure
0% of net assets
Margin
+10pp

No confidence interval: this follows from portfolio construction, not from an estimate.

Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.

Informational — does not govern

This fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.

Measured
1.0 (95% CI 0.7-1.1)
x reference VaR
Limit
2.00x
<= 2.00x reference VaR
Fund VaR
9.3%
99% / 20d
Reference
9.6%
FF5 market (mkt)

historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months

Same test, three estimators
historical
0.97x
within
parametric
0.95x
within
cornish fisher
0.89x
within

The estimators agree, which is mild evidence the number isn’t an artefact of one method.

Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.

The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.

See the long-short verdict on the factor page →

Since publication

Did the edge survive the paper coming out?

published 2004
Before publication (pre-2004)
-0.14
Sharpe · -4.0% p.a.
January 1999December 2004 · 72 mo
Since publication
0.20
Sharpe · 4.7% p.a.
January 2005July 2026 · 259 mo
Change in Sharpe+0.34the return flipped from negative to positive since publication

Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.

Consistency across eras

Is this record broadly durable, or one regime?

26 windows
Positive windows
65%
17 of 26 3-year windows made money
Worst window
-1.06
Sharpe, January 2003 – December 2005
January 1999July 2026
Median Sharpe
0.21
Dispersion
0.56
Best window
1.33

3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.

Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.

Returns

Long leg is what this fund holds — long-short is shown for reference

since January 1999
Trailing
PeriodLong legLong-short
1 yearcum.12.3%0.9%
3 yearsp.a.23.5%14.6%
5 yearsp.a.14.4%12.1%
10 yearsp.a.14.3%3.5%
Since inceptionp.a.6.8%-0.4%
Calendar years
YearLong legLong-short
20267 mo3.6%-0.2%
202523.1%16.8%
202444.2%39.5%
202313.4%-32.4%
2022-15.3%26.5%
202125.0%28.9%
202029.6%-18.2%
201918.9%-16.0%
2018-5.0%23.3%
201721.3%14.5%
20160.9%-26.5%
20150.2%33.2%
201413.9%9.5%
201334.3%-0.7%
201217.9%-16.7%
20113.6%28.4%
20107.8%-25.6%
20092.1%-59.8%
2008-25.7%88.9%
200716.2%51.4%
200614.9%-11.3%
20051.4%-3.4%
20044.1%-15.8%
200327.3%-24.3%
2002-32.8%-1.7%
2001-22.2%-7.3%
2000-20.7%15.4%
199935.2%-8.8%

Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.

Fund Facts

Ticker (pseudo)FHIR
IssuerETF Foundry Research (hypothetical)
SeriesHypothetical Model Portfolio Series (not a registered trust)
Expense ratio0.35% (placeholder)
Inception2021-11-17 (placeholder)
Listing exchangeNot listed (hypothetical)
CUSIPNot applicable (hypothetical model portfolio)
RebalanceMonthly
Holdings as ofJuly 2026
Total mkt cap (long leg)$13.31T

Methodology

The Foundry 52-Week High Industry-Neutral Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks, industry-neutralized within Fama-French industries, each month by a 52-Week High signal and holds the top decile with the highest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.

This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.

Documents (draft — hypothetical)

Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.

Summary Prospectus

Objective, fees, strategy, and key risks.

View →
Prospectus

Full strategy, model methodology, and risks.

View →
Statement of Additional Information

Policies, construction, and governance.

View →
Fact Sheet

One-page snapshot with top holdings.

View →
Daily Holdings

Full current constituent list.

View →

DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.